Pfizer: to present advances in its portfolio
(CercleFinance.com) - Pfizer will present data on its infectious disease portfolio at the forthcoming IDWeek 2023, to be held in Boston from 11 to 15 October.
Forty-five abstracts will highlight Pfizer's progress in helping to prevent and treat certain infectious diseases, particularly respiratory diseases.
Research assessing the potential public health impact of the company's Abrysvo (respiratory syncytial virus vaccine) for maternal immunization to protect infants against RSV disease will also be included.
Copyright (c) 2023 CercleFinance.com. All rights reserved.
Forty-five abstracts will highlight Pfizer's progress in helping to prevent and treat certain infectious diseases, particularly respiratory diseases.
Research assessing the potential public health impact of the company's Abrysvo (respiratory syncytial virus vaccine) for maternal immunization to protect infants against RSV disease will also be included.
Copyright (c) 2023 CercleFinance.com. All rights reserved.